Malaria treatment and prevention in pregnancy: Indications for use and adverse events associated with use of chloroquine or mefloquine

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 1 SUPPL., 1996, Pages 50-56

  Steketee, Richard W ^e   Wirima, Jack J ^a   Slutsker, Laurence ^b   Khoromana, Charles O ^a   Heymann, David L ^c   Breman, Joel G ^d  

^a UNIVERSITY OF MALAWI   (Malawi)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

CHLOROQUINE; MEFLOQUINE;

AFRICA; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; FETUS OUTCOME; FEVER; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MATERNAL DISEASE; ORAL DRUG ADMINISTRATION; PARASITEMIA; PRURITUS; VERTIGO;

AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; BODY TEMPERATURE--CHANGES; COMPARATIVE STUDIES; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; DRUGS--SIDE EFFECTS; DRUGS--THERAPEUTIC USE; EASTERN AFRICA; ENGLISH SPEAKING AFRICA; FERTILITY; FERTILITY MEASUREMENTS; MALARIA--PREVENTION AND CONTROL; MALAWI; PARASITIC DISEASES; PARITY; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; PREGNANCY; PREGNANCY OUTCOMES; PREGNANT WOMEN; REPRODUCTION; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; TREATMENT;

ADOLESCENT; ADULT; ANTIMALARIALS; CHLOROQUINE; FEMALE; FETAL DEATH; FEVER; HUMANS; MALARIA, FALCIPARUM; MALAWI; MEFLOQUINE; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; RURAL POPULATION;

EID: 0029680779     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.50     Document Type: Article

References (22)

1. World Health Organization, 1986. WHO expert committee on malaria, 18th report. World Health Organ Tech Rep Ser 735.
2. World Health Organization, 1990. Practical chemotherapy of malaria. World Health Organ Tech Rep Ser 805.
3. World Health Organization, 1994. Antimalarial Drug Policies: Data Requirements, Treatment of Uncomplicated Malaria and Management of Malaria in Pregnancy. Geneva: World Health Organization, March 14-18, 1994, WHO/MAL/94.1070.
4. Wolfe MW, Cordero JF, 1985. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J (Clin Res Ed) 290: 1466-1467.
5. Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51: 515-522.
6. Greenwood BM, Greenwood AM, Snow RW, Byass P, Bennett S, Hatib-N'Jie AB, 1989. The effects of malaria chemoprophylaxis given by traditional birth attendants on the course and outcome of pregnancy. Trans R Soc Trop Med Hyg 83: 589-594.
7. Mutabingwa TK, Malle LN, de Geus A, Oosting J, 1993. Malaria chemosuppression during pregnancy: the effect of chemosuppressive drugs on maternal parasitaemia. Trop Geogr Med 45: 6-14.
8. Nosten F, ter Kuile FO, Maelankiri L, Chongsuphajaisiddhi T, Nopdonrattakoon L, Tangkitchot S, Boudreau E, Bunnag D, White NJ, 1994. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind placebo-controlled study. J Infect Dis 169: 595-603.
9. Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Breman JG, Heymann DL, 1996. Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: the Mangochi Malaria Research Project. Am J Trop Med Hyg 55 (suppl): 8-16.
10. Ettling M, Steketee RW, Macheso A, Schultz LJ, Nyasulu Y, Chitsulo L, 1994. Malaria knowledge, attitudes and practices in Malawi: survey population characteristics. Trop Med Parasitol 45: 57-60.
11. Steketee RW, Wirima JJ, Slutsker L, Breman JG, Heymann DL, 1995. Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi. Am J Trop Med Hyg 55 (suppl): 17-23.
12. Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG, 1996. Malaria parasite infection during pregnancy and at delivery in mother, placenta and newborn: efficacy of chloroquine and mefloquine. Am J Trop Med Hyg 54 (suppl): 24-32.
13. Sowunmi A, Salako LA, Oduola AMJ, Walker O, Akindele JA, Ogundahunsi OAT, 1993. Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hvg 87: 462-463.
14. World Health Organization, 1991. Review of Central Nervous System Adverse Events Related to the Antimalarial Drug, Mefloquine (1985-1990). Geneva: World Health Organization, WHO/MAL/91.1063.
15. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, Phillips-Howard P, Nevill C, Sturchler D, 1993. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East-Africa. Lancet 341: 1299-1303.
16. Lobel HO, Miani M, Eng T. Bernard KW, Highlower AW, Campbell CC, 1993. Long-term malaria prophylaxis with weekly mefloquine. Lancet 341: 848-851.
17. Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L, 1993. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 44: 257-265.
18. Philipps-Howard PA, ter Kuile FO, 1995. CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Saf 12: 370-383.
19. Ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, Price R, Chongsuphajaisiddhi T, White NJ, 1995. Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3,673 patients. Bull World Health Organ: (in press).
20. Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G, 1991. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol 8: 174-178.
21. Phillips-Howard PA, Steffen R, Kerr L, Van Hauwere B, Schildknecht J, Fuchs E, Edwards R, 1996. Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy. Bull World Health Organ: (in press).
22. Mutabingwa TK, Malle LN, de Geus A, Oosting J, 1993. Malaria chemosuppression during pregnancy: its effect on maternal haemoglobin levels, placental malaria and birth weight. Trop Geogr Med 45: 49-55.